World Affairs

The Real Reason Behind the Nationwide Blood Pressure Pill Recall

Thousands of blood pressure medication bottles are being pulled nationwide after failing crucial FDA quality tests. Here is what patients need to know.

WhyThisBuzz DeskNov 3, 20262 min read
Share:

Millions of Americans rely on daily medications to manage hypertension, but a new nationwide recall means it is time to inspect your medicine cabinet. Federal health regulators have flagged thousands of bottles of a widely used prescription blood pressure drug for failing critical quality standards.

Here is a breakdown of what triggered the recall, which products are affected, and what patients should do next.

What Happened

New Jersey-based Macleods Pharma USA has initiated a voluntary nationwide recall of specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets.

According to the U.S. Food and Drug Administration (FDA), the affected products failed standard "dissolution specifications." This means the pills did not dissolve properly during laboratory testing, which can impact how the medication is absorbed by the body.

The ongoing recall impacts two specific batches distributed across the United States:

  • 30-count bottles: Lot number 12251163A (National Drug Code: 33342-246-07)
  • 90-count bottles: Lot number 12251163B (National Drug Code: 33342-246-10)

Both impacted lots carry an expiration date of May 31, 2027.

Why It Matters

The FDA has classified this action as a Class II recall. This categorization means that using the affected medication could potentially result in temporary or medically reversible adverse health consequences, though the likelihood of serious harm is considered remote.

If a medication fails to dissolve correctly, patients may not receive the proper dosage needed to manage their blood pressure effectively, raising health risks over time if left unaddressed.

This event follows a similar safety action from September, when Inventia Healthcare Ltd. pulled over 13,000 bottles of chlorthalidone tablets due to identical dissolution testing failures.

What Patients Should Do

If you or a family member take this combination blood pressure medication, check your prescription bottles immediately for the specified lot numbers and NDC codes.

Patients who find they have an affected bottle should not abruptly stop taking their medication without consulting a healthcare provider or pharmacist first. Abruptly halting hypertension medication can lead to dangerous spikes in blood pressure. Contact your prescribing doctor or pharmacist to discuss safe replacement options and how to return the impacted product.